Furthermore, our results showed that miR-142-3P, miR-224, miR-323, miR-484, miR-18A, miR-18B, miR-7, miR-519C, miR-519B, miR-519A, miR-17-5P, miR-20A, miR-106A, miR-106B, miR-20B, miR-519D, and miR-493 are targets of BRD2, BRD3, and BRD4 in patients with ACC. This evidence concerns the gene BRD2 and adrenal cortex carcinoma.